Clinical Trial Update: Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate

View source ↗

Summary

A completed clinical trial evaluating genetic measurements in blood cells of children taking ADHD medications Adderall or methylphenidate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Adderall (amphetamine and dextroamphetamine)
• Methylphenidate (Methylphenidate)

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Attention Deficit Hyperactivity Disorder, ADHD | Status: COMPLETED